USPH:NYE-U.S. Physical Therapy Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 92.13

Change

-0.77 (-0.83)%

Market Cap

USD 0.78B

Volume

0.37M

Analyst Target

USD 89.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-21 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-1.25 (-0.31%)

USD 104.14B
UHS Universal Health Services Inc

-1.57 (-0.65%)

USD 16.11B
THC Tenet Healthcare Corporation

-2.76 (-1.65%)

USD 16.10B
DVA DaVita HealthCare Partners Inc

-1.85 (-1.13%)

USD 13.76B
EHC Encompass Health Corp

+0.42 (+0.43%)

USD 9.32B
CHE Chemed Corp

+4.49 (+0.75%)

USD 8.90B
CON Concentra Group Holdings Paren..

-0.32 (-1.39%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.24 (-1.24%)

USD 2.59B
NHC National HealthCare Corporatio..

+0.42 (+0.33%)

USD 1.96B
AMN AMN Healthcare Services Inc

+1.56 (+3.80%)

USD 1.56B

ETFs Containing USPH

DESC 0.00 % 0.30 %

N/A

N/A
EWX SPDR® S&P Emerging Marke.. 0.00 % 0.65 %

+1.49 (+0.11%)

N/A
RNSC First Trust Small Cap US .. 0.00 % 0.60 %

+0.03 (+0.11%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.08% 43% F 35% F
Dividend Return 0.94% 75% C 34% F
Total Return -0.14% 43% F 31% F
Trailing 12 Months  
Capital Gain -18.94% 41% F 11% F
Dividend Return 1.53% 63% D 24% F
Total Return -17.41% 41% F 11% F
Trailing 5 Years  
Capital Gain -23.05% 27% F 24% F
Dividend Return 5.53% 43% F 18% F
Total Return -17.52% 27% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain 1.17% 32% F 46% F
Dividend Return 2.43% 32% F 41% F
Total Return 1.26% 63% D 30% F
Risk Return Profile  
Volatility (Standard Deviation) 26.48% 86% B+ 40% F
Risk Adjusted Return 9.19% 36% F 35% F
Market Capitalization 0.78B 54% F 60% D-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 32.40 5% 7%
Price/Book Ratio 3.25 38% 26%
Price / Cash Flow Ratio 17.31 13% 20%
Price/Free Cash Flow Ratio 22.23 17% 11%
Management Effectiveness  
Return on Equity 6.47% 52% 44%
Return on Invested Capital 10.23% 68% 66%
Return on Assets 4.43% 63% 68%
Debt to Equity Ratio 29.19% 73% 74%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.